Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HK.13.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.13.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.13.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.13.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.13.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.13.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HV.1.9EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HV.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.9ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HV.1.9ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HV.1.9EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HV.1.9EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HV.1.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HV.1.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.16EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.3.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.16ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.2.3.16ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.2.3.16EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.2.3.16EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.2.3.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.9EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.9ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.9ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.9EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.9EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CK.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CK.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.1.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CK.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CK.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CK.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CK.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CK.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.8.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CM.8.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.8.1.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CM.8.1.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CM.8.1.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CM.8.1.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CM.8.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.8.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CA.3.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CA.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CA.3.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
CA.3.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used